Search

everythinglearnresearchcommunity

for

Search:↓

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Biological therapy boosts the immune system to effectively fight melanoma.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

Iodotherapy for thyroid cancer can cause dry mouth, taste loss, infections, and hair loss, so report side effects to doctors.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Topical thyroid hormones may boost hair growth.

Advanced dermoscopy techniques improve diagnosis and treatment monitoring for Kerion celsi but don't guarantee full hair regrowth.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Ustekinumab helped three kids with alopecia areata regrow hair.

CS12192 effectively treats alopecia areata with better safety than current options.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Topical IKKα inhibitors may help prevent CCS tumours.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

Er:YAG laser therapy effectively treats Hailey-Hailey disease, leading to long-term remission and improved quality of life.

Blocking certain proteins on immune cells may help treat alopecia areata.